Periapical lesion development in rats inhibited by dexamethasone

Area of Science:

• Oral biology and pathology
• Immunology of inflammatory diseases
• Pharmacological interventions in bone resorption

Background:

• Bone resorption is a key characteristic of inflammatory periapical lesions.
• Cytokines play a crucial role in mediating bone resorption within these lesions.
• Emerging research suggests the possibility of pharmacologically modulating bone resorbing activity.

Purpose of the Study:

• To investigate the potential of pharmacological intervention to down-regulate bone resorption in induced periapical lesions.
• To evaluate the effect of systemic dexamethasone on the growth of inflammatory periapical lesions.

Main Methods:

• Periapical lesions were induced in rats by occlusal exposure of molar pulps.
• Lesion size was monitored and quantified using radiographic image analysis over 21 days.
• Systemic dexamethasone (0.5 mg/kg, every third day) was administered to assess its inhibitory effect.

Main Results:

• Induced periapical lesions demonstrated significant growth over 21 days, reaching an average area of 2.18 mm².
• Systemic dexamethasone treatment significantly inhibited lesion growth, with treated lesions averaging 1.63 mm² (p < 0.01).
• Radiographic analysis confirmed the inhibitory effect of dexamethasone on lesion expansion.

Conclusions:

• Bone resorption in inflammatory periapical lesions can be pharmacologically down-regulated.
• Systemic dexamethasone demonstrates efficacy in inhibiting the progression of these lesions.
• These findings support the development of targeted therapies for managing bone loss in periapical inflammation.